Table 4.
Postprocedural outcomes in the propensity score–matched pairs
Outcomes | Femoral access n = 62 | Carotid access n = 62 | P value |
---|---|---|---|
30-d mortality | 2 (3.2) | 3 (4.8) | 1.00∗ |
2-y mortality | 8 (12.9) | 7 (11.3) | .64∗ |
Stroke/transient ischemic attack | 0 (0) | 2 (3.2) | .23∗ |
Myocardial infarction | 0 (0) | 1 (1.6) | .32∗ |
Major bleeding | 2 (3.2) | 1 (1.6) | .60∗ |
Vascular access complications | |||
Hematoma not requiring surgery | 7 (11.3) | 2 (3.2) | .16† |
Bleeding requiring surgery | 1 (1.6) | 2 (3.2) | 1.00† |
Infection | 1 (1.6) | 0 (0) | 1.00† |
MACCE | 8 (12.9) | 10 (16.1) | .12∗ |
Acute kidney injury | 0 (0) | 0 (0) | 1.00† |
Postoperative pacemaker implantation | 18 (29.0) | 8 (12.9) | .04† |
Valve–related complications | 0 (0) | 3 (4.8) | .09† |
Sepsis | 0 (0) | 0 (0) | 1.00† |
Paravalvular regurgitation grade 1 | 0 (0) | 1 (1.6) | 1.00† |
Paravalvular regurgitation grade 2 or greater | 2 (3.2) | 1 (1.6) | 1.00† |
Transvalvular pressure gradient, mm Hg | 8.7 (4.0) | 9.6 (4.1) | .10† |
>20 mm Hg | 0 (0) | 1 (1.6) | 1.00† |
MACCE, Major adverse cardiac and cerebrovascular complications.
Log-rank test.
Fisher exact test.